Here are three points:
1. The market is expected to hit $2.75 billion by 2025.
2. By 2025, the market is estimated to increase at a compound annual growth rate of 19.1 percent.
3. Increased government regulation on improved infection control practices, molecular diagnostic technological advancements and efforts to lower infections are spurring market growth.
More articles on quality and infection control:
10 top ASC citations from the Ohio Department of Health
Biocompatibles, guilty to misbranding, to pay $36M: 4 key notes
Coaching patients to ensure educated medical decisions: 6 observations
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
